Search

HIGH-POWER LASER IN THE MANAGEMENT OF ORAL PROLIFERATIVE VERRUCOUS LEUKOPLAKIA: A 3-YEAR FOLLOW-UP CASE REPORT.

Oral Cavity

Juliana Mota Siqueira, PhD¹; Daphine Caxias Travassos, MSc²; Emilia Maria Gomes Aguiar, PhD¹; Luana de Campos, PhD³; Fabio Daumas Nunes, PhD, Professor¹

¹University of São Paulo; ²Private Practice; ³Universidade de Santo Amaro

EXAMINING THE IMPACT OF RACE AND GENDER ON THE RATE OF POSITIVE SURGICAL MARGINS IN YOUNG PATIENTS WITH ORAL CAVITY SQUAMOUS CELL CARCINOMA

Oral Cavity

Jacob S Brady, MD; Austin Lam, MD; Neeraja Konuthula, MD; Emily Marchiano, MD; Neal D Futran, MD, DMD; Brittany Barber, MD, MSc

University of Washington

PHASE II CLINICAL TRIAL OF APG-157 FOR TREATMENT OF ORAL AND OROPHARYNGEAL SQUAMOUS CELL CARCINOMA: PROMISING THERAPEUTIC EFFECT

Oral Cavity

Marilene B Wang, MD¹; Saroj Basak, PhD¹; Daniel S Shin, MD, PhD¹; Neda Moatamed, MD¹; Jin Zhong, MD²; Parag Mehta, PhD³; Eri Srivatsan, PhD¹

¹UCLA David Geffen School of Medicine; ²VA Greater Los Angeles Healthcare System; ³Aveta Biomics, Inc.

ACCURACY OF MRI AND INTRAORAL USG IN DETECTION AND MEASUREMENT OF DEPTH OF INVASION COMPARED TO THE CRITERION STANDARD HISTOPATHOLOGY IN PATIENTS OF CARCINOMA OF ORAL TONGUE FOR GUIDING INTRA OPERATIVE TUMOR RESECTION .

Oral Cavity

Deepak Saharan, Dr, MBBS, MS, MCh; Roshan Kumar Verma, Professor; Naresh Kumar Panda, Professor; Jaimanti Bakshi, Professor; Amanjit Bal, Professor; Rijuneeta Gupta, Professor; Chirag Ahuja, Professor; Amit Bahl, Professor; Sourabha K Patro, Dr

PGIMER, Chandigarh

RELIABILITY OF DIAGNOSTIC BIOPSY IN ASSESSING DEPTH OF TUMOUR IN CT1-T2N0 OF ORAL SQUAMOUS CELL CARCINOMAS

Oral Cavity

Vilavan Koompirochana, MBBCh, BDS, PGDip, AKC; Axel Sahovaler, MD; Clare Schilling, MBBD, BDS, FRCS, OMFS, PhD

University College London Hospital

INTER-OBSERVER VARIABILITY ELEMENT IN THE GRADING OF ORAL EPITHELIAL DYSPLASIA- A STUDY IN 1000 ORAL POTENTIALLY MALIGNANT DISORDERS

Oral Cavity

Lekshmi Pradeep, MDS¹; Sumsum P Sunny, MDS¹; Satyajit T²; Shubha Gurudath²; Keerthi G²; Subhashini Raghavan²; Vivek Shetty³; Vidya Bushan R³; Vijay Pillai³; Praveen Birur²; Moni A Kuriakose³; Amritha Suresh¹

¹Integrated Head and Neck Oncology Program, Mazumdar Shaw Center for Translational Research, Mazumdar Shaw Medical Foundation, Bangalore; ²KLE Belgaum Institute Of Dental Sciences; ³Department of Head and Neck Oncology, Mazumdar Shaw Cancer Center, Narayana Health City, Bangalore

'HIGH-RISK SITE?' OCCULT METASTATIC RATE AND CANCER SURVIVAL OF TUMOURS OF FLOOR OF MOUTH (FOM) COMPARED TO TONGUE. ANALYSIS OF 529 CT1-T2 N0 CASES STAGED BY SENTINEL NODE BIOPSY.

Oral Cavity

Clare Schilling, MD, PhD¹; Isabel Sassoon, Dr²; Mark McGurk, Prof¹

¹Head and Neck Academic Centre, University College London, Department of Head and Neck Surgery University College Hospital, London; ²Brunel University

ONCOLOGIC SIGNIFICANCE OF THERAPEUTIC DELAYS IN ORAL CAVITY CANCER: A CANADIAN MULTI-CENTER STUDY

Oral Cavity

Gabriel S Dayan¹; Houda Bahig, MD, PhD²; Stephanie Johnson-Obaseki, MD, MPH³; Antoine Eskander, MD, ScM⁴; Xinyuan Camilla Hong, MD³; Shamir Chandarana, MD, MSc⁵; John R de Almeida, MD, MSc⁶; Anthony C Nichols, MD⁷; Michael Hier, MD⁸; Mathieu Belzile, MD, DMD⁹; Marc Gaudet, MD, MSc¹⁰; Joseph Dort, MD, MSc⁵; T Wayne Matthews, MD⁵; Robert Hart, MD⁵; David P Goldstein, MD, MSc⁶; Christopher Yao, MD⁶; Ali Hosni, MD, PhD¹¹; Danielle MacNeil, MD, MSc⁷; James Fowler, MD⁷; Alex M Mlynarek, MD, MSc⁸; Gregoire Morand, MD⁸; Khalil Sultanem, MD¹²; Tareck Ayad, MD¹; Kevin Higgins, MD, MDs⁴; Carlos Khalil⁴; Mark Khoury⁴; Anastasios Maniakas, MD, PhD¹³; Bernard Fortin, MD, MSc¹⁴; Apostolos Christopoulos, MD, MSc¹

¹Department of Otolaryngology-Head and Neck Surgery, Centre Hospitalier de l'Université de Montréal (CHUM), University of Montreal, Montreal, Quebec, Canada; ²Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal (CHUM), University of Montreal, Montreal, Quebec, Canada; ³Department of Otolaryngology-Head and Neck Surgery, University of Ottawa, Ottawa, Ontario, Canada; ⁴Department of Otolaryngology-Head and Neck Surgery, Sunnybrook Health Science Centre, University of Toronto, Toronto, Ontario, Canada; ⁵Department of Otolaryngology-Head and Neck Surgery, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada; ⁶Department of Otolaryngology-Head and Neck Surgery, University Health Network, University of Toronto, Toronto, Ontario, Canada; ⁷Department of Otolaryngology-Head and Neck Surgery, London Health Sciences Centre, Western University, London, Ontario, Canada; ⁸Department of Otolaryngology-Head and Neck Surgery, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; ⁹Department of Otolaryngology-Head and Neck Surgery, Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, Quebec, Canada; ¹⁰Department of Radiation Oncology, University of Ottawa, Ottawa, Ontario, Canada; ¹¹Department of Radiation Oncology, University Health Network, University of Toronto, Toronto, Ontario, Canada; ¹²Department of Radiation Oncology, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; ¹³Department of Otolaryngology-Head and Neck Surgery, MD Anderson Cancer Center, University of Texas, Houston, Texas, United States; ¹⁴Department of Radiation Oncology, Maisonneuve Rosemont Hospital, University of Montreal, Montreal, Quebec, Canada

DETERMINANTS OF EXTRA-CAPSULAR SPREAD (OR EXTRA-NODAL EXTENSION) OCCURRENCE AND LYMPHATIC PROGRESSION IN ORAL TONGUE AND ORO-, HYPO-PHARYNGEAL CANCER

Oral Cavity

Taehwan Kim, MD; Yungjee Kang, MD; Eunhye Kim; Nayeon Choi, MD; Heejun Yi; Heejung Kim; Man Ki Chung, MD, PhD; Young-Ik Son; Chung-Hwan Baek, MD, PhD; Han-Sin Jeong, MD, PhD; Yujin Heo, MD; Changhee Lee, MD

Samsung Medical Center

HOW TO PERFORM DUAL MODALITY MAGNETIC-FLUORESCENCE SENTINEL LYMPH NODE BIOPSY IN ORAL SQUAMOUS CELL CARCINOMA: REFINED PROCEDURAL STEPS FOLLOWING COMPLETION OF A PHASE 1 CLINICAL TRIAL

Oral Cavity

Giri Krishnan, MBBS, PHD¹; Aidan Cousins, PhD²; Shridhar Krishnan, MBBS³; Angela Walls⁴; Andrew Dwyer, MBBS⁴; Benjamin Thierry, PhD²; James Badlani, MBBS³; JC Hodge, MBBS¹; Suren Krishnan, MBBS¹; Andrew Foreman, MBBS, PhD¹

¹Department of Otolaryngology, Head and Neck Surgery, The University of Adelaide, Adelaide, SA; ²Future Industries Institute, The University of South Australia; ³Department of Oral and Maxillofacial Surgery, The University of Adelaide, Adelaide, SA; ⁴Clinical Research Imaging Centre, Adelaide, SA